Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome is a rare, genetic, neurological disorder characterized by mild to severe developmental delay and speech impairment, truncal hypotonia, abnormalities of vision (including cortical visual impairment and abnormal visual-evoked potentials), progressive brain atrophy mainly affecting the cerebellum, and shortened or atrophic corpus callosum. Other clinical findings may include increased muscle tone in the extremities, dystonic posturing, hyporeflexia, scoliosis, postnatal microcephaly and variable facial dysmorphism (e.g. deep-set eyes, gingival hyperplasia, short philtrum and retrognathia).
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome.
16 publications have been identified in PubMed for global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome. Research spans Case Report / Case Series (67%) and Review / Meta-Analysis (33%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 10 | 67% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 1:52 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
5 |
33% |
Akyüzlüer Güneş MS (2026). [PMID: 42232680](https://pubmed.ncbi.nlm.nih.gov/42232680/). *Mol Syndromol*. [Case Report / Case Series]
Lateef S (2026). [PMID: 41836309](https://pubmed.ncbi.nlm.nih.gov/41836309/). *Case reports in neurology*. [Case Report / Case Series]
Peter B (2026). [PMID: 40891523](https://pubmed.ncbi.nlm.nih.gov/40891523/). *American journal of medical genetics. Part A*. [Case Report / Case Series]
Garavatti E (2026). [PMID: 41962271](https://pubmed.ncbi.nlm.nih.gov/41962271/). *Pediatric neurology*. [Case Report / Case Series]
Manav Yigit Z (2026). [PMID: 41545183](https://pubmed.ncbi.nlm.nih.gov/41545183/). *Journal of medical genetics*. [Case Report / Case Series]
Sharma R (2026). [PMID: 41653646](https://pubmed.ncbi.nlm.nih.gov/41653646/). *Neuromuscular disorders : NMD*. [Review / Meta-Analysis]
Yilmaz I (2026). [PMID: 42105148](https://pubmed.ncbi.nlm.nih.gov/42105148/). *Cerebellum*. [Case Report / Case Series]
Solijon KLK (2025). [PMID: 39849212](https://pubmed.ncbi.nlm.nih.gov/39849212/). *Journal of neural transmission (Vienna, Austria : 1996)*. [Case Report / Case Series]
Abdel-Ghafar SF (2025). [PMID: 41184612](https://pubmed.ncbi.nlm.nih.gov/41184612/). *Journal of molecular neuroscience : MN*. [Case Report / Case Series]
Fazio A (2025). [PMID: 41465117](https://pubmed.ncbi.nlm.nih.gov/41465117/). *Genes*. [Review / Meta-Analysis]